BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25961022)

  • 1. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic Acid Methyl Ester Inhibited Hepatocellular Carcinoma Growth in Bel-7402 Cells and Its Resistant Variants by Activation of NOX4 and SIRT3.
    Li Y; Wang W; Xu X; Sun S; Xu X; Qu XJ
    Biomed Res Int; 2015; 2015():491205. PubMed ID: 25961022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) inhibited human hepatocellular carcinoma growth through upregulation of Sirtuin-3 (SIRT3).
    Li Y; Wang W; Xu X; Sun S; Qu XJ
    Biomed Pharmacother; 2015 Feb; 69():125-32. PubMed ID: 25661348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM): its anti-cancer efficacy and intercalation mechanism identified via multi-model systems.
    Wang W; Zhao M; Wang Y; Liu J; Wu J; Kang G; Peng S
    Mol Biosyst; 2011 Mar; 7(3):766-72. PubMed ID: 21116565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells.
    Jo H; Park Y; Kim T; Kim J; Lee JS; Kim SY; Chung JI; Ko HY; Pyun JC; Kim KS; Lee M; Yun M
    BMC Cancer; 2020 Apr; 20(1):332. PubMed ID: 32306906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a novel tripeptide, tyroserleutide (YSL), on cell cycle progression of human hepatocellular carcinoma.
    Wang C; Wang S; Lu R; Zhao L; Zhu ZF; Xu Q; Lv JQ; Wang LL; Fu Z; Lin G; Yao Z
    Anticancer Drugs; 2009 Aug; 20(7):534-42. PubMed ID: 19491661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
    Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
    Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate.
    Wang CT; Meng M; Zhang JC; Jin CJ; Jiang JJ; Ren HS; Jiang JM; Qin CY; Yu DQ
    Chin Med J (Engl); 2008 Sep; 121(17):1707-11. PubMed ID: 19024104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU.
    Tang B; Hu Z; Li Y; Yuan S; Wang Z; Yu S; He S
    Mol Med Rep; 2016 Jan; 13(1):59-66. PubMed ID: 26549838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression.
    Crosas-Molist E; Bertran E; Sancho P; López-Luque J; Fernando J; Sánchez A; Fernández M; Navarro E; Fabregat I
    Free Radic Biol Med; 2014 Apr; 69():338-47. PubMed ID: 24509161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT3 functions as a tumor suppressor in hepatocellular carcinoma.
    Zeng X; Wang N; Zhai H; Wang R; Wu J; Pu W
    Tumour Biol; 2017 Mar; 39(3):1010428317691178. PubMed ID: 28347248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirt3 promotes hepatocellular carcinoma cells sensitivity to regorafenib through the acceleration of mitochondrial dysfunction.
    Wang R; Liu Y; Mi X; Chen Q; Jiang P; Hou J; Lin Y; Li S; Ji B; Fang Y
    Arch Biochem Biophys; 2020 Aug; 689():108415. PubMed ID: 32562663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of SIRT3 in primary hepatocellular carcinoma and the mechanism of its tumor suppressing effects.
    Liu Y; Liu YL; Cheng W; Yin XM; Jiang B
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):978-998. PubMed ID: 28338198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
    Mei N; Zhao N; Tian T; Jiao M; Li C
    Pharmacol Res Perspect; 2021 Feb; 9(1):e00715. PubMed ID: 33486902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
    Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
    Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells.
    Wang CJ; Guo X; Zhai RQ; Sun C; Xiao G; Chen J; Wei MY; Shao CL; Gu Y
    Eur J Med Chem; 2021 Nov; 224():113671. PubMed ID: 34237623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
    Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
    Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma.
    Lee JH; Lee H; Yun SM; Jung KH; Jeong Y; Yan HH; Hong S; Hong SS
    Cancer Lett; 2013 Feb; 329(1):99-108. PubMed ID: 23142281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
    Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
    J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amantadine inhibits cellular proliferation and induces the apoptosis of hepatocellular cancer cells in vitro.
    Lan Z; Chong Z; Liu C; Feng D; Fang D; Zang W; Zhou J
    Int J Mol Med; 2015 Sep; 36(3):904-10. PubMed ID: 26201988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.